Mesenchymal Stromal Cells for the Treatment of Graft Versus Host Disease

Overview of attention for article published in Frontiers in immunology, October 2021

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (86th percentile)
High Attention Score compared to outputs of the same age and source (89th percentile)

So far, Altmetric has seen 23 X posts from 20 X users, with an upper bound of 63,520 followers.

RT @TheEBMT_Trainee: REACH2 trial: https://t.co/w1hveCzIx2 Mesenchymal Stromal Cells for GVHD: https://t.co/ta07YdSpe3 ECP for GVHD: https:…

RT @TheEBMT_Trainee: REACH2 trial: https://t.co/w1hveCzIx2 Mesenchymal Stromal Cells for GVHD: https://t.co/ta07YdSpe3 ECP for GVHD: https:…

RT @TheEBMT_Trainee: REACH2 trial: https://t.co/w1hveCzIx2 Mesenchymal Stromal Cells for GVHD: https://t.co/ta07YdSpe3 ECP for GVHD: https:…

REACH2 trial: https://t.co/w1hveCzIx2 Mesenchymal Stromal Cells for GVHD: https://t.co/ta07YdSpe3 ECP for GVHD: https://t.co/EoZB0PbMnr ESPEN Nutrition in cancer guideline: https://t.co/mUnZ93NjbD Nutrition in HSCT: https://t.co/4UHNgGarKr

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 19 additional X posts.